MSH|^~\&|SHIRE|CPP|HODS|HODS|20250905105148||ORU^R01|RPRD-250905-0||2.3.1
PID|1||1234567890^^^^PATNUMBER~0987654321^^^^ALTNUMBER||Surname^Firstname||20001013|M|||^^^^AB1 2CD
OBR|1||||||20250905|||||||||||||25.3709|||||F|||||||SA||CH
OBX|1|FT|CYTO||Karyotype: FISH ON PARAFFIN EMBEDDED TISSUE                                           
OBX|2|FT|CYTO||                                                                                      
OBX|3|FT|CYTO||FISH Result: IRF4/DUSP22 gene rearrangement detected                                  
OBX|4|FT|CYTO||No evidence of MYC, IGH::MYC, BCL2 or BCL6 rearrangements.                            
OBX|5|FT|CYTO||                                                                                      
OBX|6|FT|CYTO||Fluorescence in situ hybridisation (FISH) studies were carried out using the          
OBX|7|FT|CYTO||following Cytocell gene probes; MYC Breakapart, IGH-MYC LPS Dual Fusion, BCL2         
OBX|8|FT|CYTO||Breakapart, BCL6 Breakapart, and MyProbe IRF4/DUSP22 Breakapart to detect             
OBX|9|FT|CYTO||rearrangements of 6p25 found in B- and T-cell lymphomas.                              
OBX|10|FT|CYTO||                                                                                      
OBX|11|FT|CYTO||There was no evidence of MYC, IGH::MYC, BCL2 or BCL6 gene rearrangements in multiple  
OBX|12|FT|CYTO||tissue areas examined.                                                                
OBX|13|FT|CYTO||                                                                                      
OBX|14|FT|CYTO||A signal pattern consistent with IRF4 gene rearrangement was seen in multiple tissue  
OBX|15|FT|CYTO||areas examined.                                                                       
OBX|16|FT|CYTO||                                                                                      
OBX|17|FT|CYTO||IRF4 rearrangement is recognised finding in Large B-cell lymphoma and is consistent   
OBX|18|FT|CYTO||with the diagnosis of 'Large B-cell lymphoma with IRF4 rearrangement' (WHO            
OBX|19|FT|CYTO||Classification 2022; ICD-O code 9698/3).                                              
OBX|20|FT|CYTO||                                                                                      
OBX|21|FT|CYTO||Please note that the probe used in this assay cannot distinguish between IRF4 and     
OBX|22|FT|CYTO||DUSP22 gene rearrangements and this result should be interpreted in conjunction with  
OBX|23|FT|CYTO||clinical factors and other testing modalities.                                        
OBX|24|FT|CYTO||                                                                                      
OBX|25|FT|CYTO||Uncommon cases of Ig translocations with atypical breakpoints outside the common      
OBX|26|FT|CYTO||cluster regions or resulting from alternative genetic mechanisms may not be detected  
OBX|27|FT|CYTO||by the assays used in this report.                                                    
OBX|28|FT|CYTO||Conclusion: IRF4/DUSP22 gene rearrangement detected by FISH                           
OBX|29|FT|CYTO||No evidence of MYC, IGH::MYC, BCL2 or BCL6 rearrangements by FISH                     
